Skip to content

Advertisement

Open Access

Correction to: Design and rationale of the non-interventional, edoxaban treatment in routiNe clinical prActice in patients with venous ThromboEmbolism in Europe (ETNA-VTE-Europe) study

  • Alexander T. Cohen1Email author,
  • Cihan Ay2,
  • Philippe Hainaut3,
  • Hervé Décousus4,
  • Ulrich Hoffmann5,
  • Sean Gaine6,
  • Michiel Coppens7,
  • Pedro Marques da Silva8,
  • David Jimenez9,
  • Beatrice Amann-Vesti10,
  • Bernd Brüggenjürgen11,
  • Pierre Levy12,
  • Julio Lopez Bastida13,
  • Eric Vicaut14,
  • Petra Laeis15,
  • Eva-Maria Fronk15,
  • Wolfgang Zierhut15,
  • Thomas Malzer15,
  • Peter Bramlage16,
  • Giancarlo Agnelli17 and
  • on behalf of the ETNA-VTE-Europe investigators
Thrombosis Journal201816:18

https://doi.org/10.1186/s12959-018-0173-5

Published: 31 May 2018

The original article was published in Thrombosis Journal 2018 16:9

Correction to: Thrombosis Journal (2018) 16:9 DOI https://doi.org/10.1186/s12959-018-0163-7

Following publication of the original article [1], the authors reported that one of the authors’ name was given incorrectly. In this Correction the incorrect and correct author name are shown. The original publication of this article has been corrected.

Originally the author name has been published as:
  • David Jimenez Castro

The correct author name is:
  • David Jimenez

Notes

Declarations

Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.

Authors’ Affiliations

(1)
Guy’s and St Thomas’ NHS Foundation Trust, King’s College London, London, UK
(2)
Clinical Division of Haematology and Haemostaseology, Department of Medicine I, Medical University of Vienna, Vienna, Austria
(3)
Department of General Internal Medicine, Cliniques Universitaires Saint Luc, UCL, Bruxelles, Belgium
(4)
Centre Hospitalier Universitaire de Saint-Etienne, Saint-Priest En Jarez, France
(5)
Division of Angiology, Medical Clinic IV, University Hospital, Ludwig-Maximilians-University, Munich, Germany
(6)
National Pulmonary Hypertension Unit, Mater Misericordiae University Hospital, Dublin, Ireland
(7)
Department of Vascular Medicine, Academic Medical Center, Amsterdam, The Netherlands
(8)
Department of Internal Medicine, Arterial Investigation Unit, Hospital de Santa Marta, Lisbon, Portugal
(9)
Respiratory Department, Ramón y Cajal Hospital, Madrid, Spain
(10)
Division of Angiology, University Hospital Zurich, Zurich, Switzerland
(11)
Institute for Health Economics, Steinbeis-University, Berlin, Germany
(12)
LEGOS, Université Paris – Dauphine, Paris, France
(13)
University of Castilla-La Mancha, Talavera de la Reina, Spain
(14)
Department of Medicine, Université Paris Descartes, Paris, France
(15)
Daiichi Sankyo Europe GmbH, Munich, Germany
(16)
Institute for Pharmacology and Preventive Medicine, Berlin, Germany
(17)
Internal and Cardiovascular Medicine-Stroke Unit, University of Perugia, Perugia, Italy

Reference

Copyright

© The Author(s). 2018

Advertisement